Skip to Content
Biotechnology and health

Americans are okay with gene-editing embryos to create healthier babies

The US public approves of gene-tailored babies but fears that the wealthy will use the technology first, leading to inequality.

The survey: The Pew Research Center asked 2,537 US adults how they felt about changing the genetic characteristics of babies using gene-editing tools.

Wide public support: Surprise. Seven out of 10 people said they think changing a baby’s genes is an appropriate use of technology, but only if it’s to treat or avoid a serious disease.

But only for healthy tots: When asked, only 20 percent thought making “more intelligent” humans would be acceptable. Most believed that using gene editing to increase intelligence would be taking things “too far.”

Top fear: Americans may be generally okay with genetically modified babies, but they still think negative results are more likely than positive ones. Survey respondents ranked inequality as their top worry. More than half think it’s “very likely” that gene-edited babies will only be available to the wealthy.

Deep Dive

Biotechnology and health

What to know about this autumn’s covid vaccines

New variants will pose a challenge, but early signs suggest the shots will still boost antibody responses.

A biotech company says it put dopamine-making cells into people’s brains

The experiment to treat Parkinson’s is a critical early test of stem cells’ potential to tackle serious disease.

Tiny faux organs could crack the mystery of menstruation

Researchers are using organoids to unlock one of the human body’s most mysterious—and miraculous—processes.

How AI can help us understand how cells work—and help cure diseases

A virtual cell modeling system, powered by AI, will lead to breakthroughs in our understanding of diseases, argue the cofounders of the Chan Zuckerberg Initiative.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.